UNITED
STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) June 11, 2008 (June 11, 2008)
KMG Chemicals, Inc.
(Exact name of registrant as specified in its charter)
TEXAS |
|
000-29278 |
|
75-2640529 |
(State or other jurisdiction |
|
(Commission |
|
(IRS Employer |
of incorporation) |
|
File Number) |
|
Identification No.) |
9555 W. Sam Houston Pkwy S., Suite 600, Houston, Texas |
|
77099 |
(Address of principal executive offices) |
|
(Zip Code) |
Registrants telephone number, including area code 713-600-3800
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o |
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
|
|
o |
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
|
|
o |
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
|
|
|
o |
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 2.02 Results of Operations and Financial Condition.
On June 11, 2008, we issued a press release announcing our operating results for the third quarter of fiscal year 2008. A copy of the press release is furnished as Exhibit 99.1 hereto.
Item 7.01 Regulation FD Disclosure
On June 11, 2008, a conference call was held by the Company discussing operating results for the third quarter of the fiscal year 2008. A copy of the transcript of that call is furnished as Exhibit 99.2 hereto.
Item 9.01 Financial Statements and Exhibits
(d) Exhibits.
99.1 Press Release, dated June 11, 2008
99.2 Transcript of Conference Call, dated June 11, 2008
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
KMG Chemicals, Inc. |
|
|
|||
|
|
|
|||
|
|
|
|||
By: |
/s/ John V. Sobchak |
|
Date: June 11, 2008 |
||
|
John V. Sobchak, |
|
|||
|
Vice President and Chief Financial Officer |
|
|||
3